{"transactions":[{"id":700792,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"RSUs","published_at":"2026-07-31T00:24:59.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Vivani common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire."}],"balance_after":100000,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001753926-26-001282","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392626001282/form4.xml","form_type":"4"}},{"id":700791,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2026-07-31T00:24:59.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.31,"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001753926-26-001282","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392626001282/form4.xml","form_type":"4"}},{"id":1149465,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"RSUs","published_at":"2025-05-15T00:18:48.000Z","date":"2025-05-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Vivani common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The performance based RSUs shall vest in three stages: one-third when the stock price closes at or above $3.15 for three consecutive days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to close at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire."}],"balance_after":100000,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001753926-25-000822","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392625000822/form4.xml","form_type":"4"}},{"id":1149464,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2025-05-15T00:18:48.000Z","date":"2025-05-12","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.03,"expiration_date":"2035-05-11","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001753926-25-000822","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392625000822/form4.xml","form_type":"4"}},{"id":1517762,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-14T22:52:12.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Vivani common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire."}],"balance_after":100000,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001753926-24-000966","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392624000966/ownership.xml","form_type":"4"}},{"id":1517761,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2024-05-14T22:52:12.000Z","date":"2024-05-10","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.81,"expiration_date":"2034-05-09","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001753926-24-000966","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392624000966/ownership.xml","form_type":"4"}},{"id":1963687,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"RSU","published_at":"2023-03-09T02:32:14.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of Vivani common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"First third of RSUs vest when the stock price is at or above $3.15 for three consecutive business days. Second third vests one year after that. Final third vests one year after the second third. If the RSUs fail to reach $3.15 for three consecutive business days within a four year term from the date of the grant the RSUs expire."}],"balance_after":100000,"derivative":{"exercise_date":"2023-03-06","expiration_date":"2027-03-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001753926-23-000259","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392623000259/ownership.xml","form_type":"4"}},{"id":1963686,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock Option","published_at":"2023-03-09T02:32:14.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The stock options have a 10-year term and vest immediately when share price closes at $6.30 for three consecutive business days. If the options fail to reach $6.30 for three consecutive business days within a four year term from the date of grant the options expire."}],"balance_after":200000,"derivative":{"exercise_price":1.09,"exercise_date":"2023-03-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001753926-23-000259","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392623000259/ownership.xml","form_type":"4"}},{"id":2023003,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2023-02-10T23:42:49.000Z","date":"2023-02-08","kind":"gift","acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock gifted to a non-family member."}],"balance_after":3605015,"source":{"system":"sec-edgar","filing":"0001753926-23-000124","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392623000124/ownership.xml","form_type":"4"}},{"id":2048815,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock Option","published_at":"2023-01-24T02:13:06.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock options have a 10-year term and vest 25% at one-year and monthly for 36 months thereafter on an equal basis."}],"balance_after":200000,"derivative":{"exercise_price":1.27,"exercise_date":"2024-01-19","expiration_date":"2033-01-19","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001753926-23-000082","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392623000082/ownership.xml","form_type":"4"}},{"id":2170113,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Warrant","published_at":"2022-08-31T22:43:22.000Z","date":"2022-08-30","kind":"other","acquired":true,"shares":4585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision Medical, Inc., consummated on August 30, 2022 pursuant to the Agreement and Plan of Merger dated February 4, 2022."}],"balance_after":4585,"derivative":{"exercise_price":3.15,"exercise_date":"2022-08-30","expiration_date":"2023-12-14","underlying":"Common Stock","underlying_shares":4585},"source":{"system":"sec-edgar","filing":"0001753926-22-001196","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392622001196/ownership.xml","form_type":"4"}},{"id":2170112,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Warrant","published_at":"2022-08-31T22:43:22.000Z","date":"2022-08-30","kind":"other","acquired":true,"shares":31774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision Medical, Inc., consummated on August 30, 2022 pursuant to the Agreement and Plan of Merger dated February 4, 2022."}],"balance_after":31774,"derivative":{"exercise_price":3.15,"exercise_date":"2022-08-30","expiration_date":"2023-11-26","underlying":"Common Stock","underlying_shares":31774},"source":{"system":"sec-edgar","filing":"0001753926-22-001196","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392622001196/ownership.xml","form_type":"4"}},{"id":2170111,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock Option","published_at":"2022-08-31T22:43:22.000Z","date":"2022-08-30","kind":"other","acquired":true,"shares":60373,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the replacement option to be issued by Vivani Medical, Inc. (f/k/a Second Sight Medical\n Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the\nAgreement and Plan of Merger entered into on February 4, 2022."},{"field":"shares","element":"transactionShares","label":"F4","text":"The option vests 1/48 per month over the four years after the date of grant commencing on\n December 12, 2018, and the balance thereafter vests in full on the fifth anniversary of the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The option vests 1/48 per month over the four years after the date of grant commencing on\n December 12, 2018, and the balance thereafter vests in full on the fifth anniversary of the date of grant."}],"balance_after":60373,"derivative":{"exercise_price":3.15,"exercise_date":"2022-08-30","expiration_date":"2028-11-13","underlying":"Common Stock","underlying_shares":60373},"source":{"system":"sec-edgar","filing":"0001753926-22-001196","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392622001196/ownership.xml","form_type":"4"}},{"id":2170110,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-31T22:43:22.000Z","date":"2022-08-30","kind":"other","acquired":true,"shares":90558,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Trusts"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical\n Inc. consummated August 30, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Represents shares of common stock held by three trusts for the benefit of the children of the\nReporting Person, over which the Reporting Person and his spouse have joint voting and diapositive\n authority. The Reporting Person disclaims pecuniary ownership in the shares of common stock held by\nthe three trusts. Excludes 77,331 shares of common stock held by MFE, LLC in which the Reporting\nPerson has a 10% ownership interest and therefore a pecuniary interest in such shares, but over which\nthe Reporting Person does not have any voting or diapositive authority."}],"balance_after":90558,"source":{"system":"sec-edgar","filing":"0001753926-22-001196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392622001196/ownership.xml","form_type":"4"}},{"id":2170109,"issuer":{"id":6636,"kind":"organization","name":"Vivani Medical, Inc."},"owners":[{"id":27810,"kind":"person","name":"Mendelsohn Adam","position":1,"cik":"0001940008","reported_name":"Mendelsohn Adam","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2022-08-31T22:43:22.000Z","date":"2022-08-30","kind":"other","acquired":true,"shares":3622015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical\n Inc. consummated August 30, 2022."}],"balance_after":3622015,"source":{"system":"sec-edgar","filing":"0001753926-22-001196","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1940008/000175392622001196/ownership.xml","form_type":"4"}}]}